Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2834
https://www.abbvie.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
- Apr 25th, 2024 8:48 pm
UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
- Apr 25th, 2024 12:44 pm
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
- Apr 25th, 2024 12:33 pm
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
- Apr 25th, 2024 12:00 pm
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
- Apr 24th, 2024 4:05 pm
4 Large Drug Stocks to Hold on to Amid Industry Challenges
- Apr 24th, 2024 2:09 pm
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
- Apr 24th, 2024 1:19 pm
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
- Apr 24th, 2024 10:20 am
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s among 10 stocks set to surge
- Apr 23rd, 2024 7:09 pm
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
- Apr 23rd, 2024 2:01 pm
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
- Apr 23rd, 2024 1:15 pm
Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
- Apr 23rd, 2024 12:00 pm
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
- Apr 22nd, 2024 4:56 pm
Buying the Dip in These 3 Undervalued Dividend Stocks
- Apr 22nd, 2024 1:47 pm
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
- Apr 19th, 2024 8:11 pm
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
- Apr 19th, 2024 6:30 pm
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
- Apr 19th, 2024 2:00 pm
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
- Apr 19th, 2024 1:15 pm
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
- Apr 18th, 2024 7:44 pm
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
- Apr 18th, 2024 4:18 pm
Scroll